4//SEC Filing
Scots-Knight Denise 4
Accession 0000950170-24-106976
CIK 0001719714other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:50 PM ET
Size
8.3 KB
Accession
0000950170-24-106976
Insider Transaction Report
Form 4
Pollard-Knight Denise
Chief Executive Officer
Transactions
- Sale
American Depositary Shares representing Ordinary Shares
2024-09-13$4.22/sh−60,046$253,454→ 808,921 total - Sale
American Depositary Shares representing Ordinary Shares
2024-09-12$4.47/sh−28,611$127,968→ 868,967 total
Footnotes (6)
- [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- [F2]Reporting Person also beneficially owns 4 ordinary shares, nominal value of GBP 0.003 per ordinary share, of the Issuer.
- [F3]Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F4]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.37 to $4.62, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.01 to $4.43, inclusive.
- [F6]Includes 1,200 ADSs jointly owned by Reporting person and her spouse.
Documents
Issuer
Mereo BioPharma Group plc
CIK 0001719714
Entity typeother
Related Parties
1- filerCIK 0001297000
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:50 PM ET
- Size
- 8.3 KB